Peter Fernandes - Feb 10, 2023 Form 4 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role
CHIEF EXECUTIVE OFFICER
Signature
/s/ Peter Fernandes
Stock symbol
BLPH
Transactions as of
Feb 10, 2023
Transactions value $
$152,000
Form type
4
Date filed
2/14/2023, 03:46 PM
Previous filing
Dec 13, 2022
Next filing
Jun 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLPH Stock Options (right to buy) Award $152K +100K $1.52 100K Feb 10, 2023 Common Stock 100K $1.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter.